Editors’ Picks, July 2024: Risks of CAR T-cell Therapy, Sarcoma Advances, and More
The AACR journal editors' picks for July 2024 include a review of the risks from CAR T-cell therapy, advances...
The AACR journal editors' picks for July 2024 include a review of the risks from CAR T-cell therapy, advances...
The FDA issued 18 oncology-related approvals in Q2 2024 including two first-in-class drugs and a bispecific T-cell engager for...
The June edition of Editors’ Picks includes a clinical trial that clinched a new FDA approval for adagrasib, a...
A recap of the plenary sessions, cutting-edge science, clinical trials, and more covered by the AACR blog.
The editors of AACR's journals highlight studies from May, including machine learning, savings from quitting smoking, and more.
The latest installment of this quarterly series highlights innovative research approaches reported at the AACR Annual Meeting 2024.
Experience the annual undergraduate poster competition at the AACR Annual Meeting through photos.
April picks include metabolic interventions for acute myeloid leukemia, new inhibitors of KRAS signaling, and more.
The FDA issued 14 oncology approvals this quarter, including the first tumor-infiltrating lymphocyte therapy.
A few important details to help attendees get the most out of their experience at the AACR Annual Meeting...